WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 9 fonti

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

Raccontata da

biopharmadive.com

medpagetoday.com

arstechnica.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

arstechnica.comStai leggendo1 mesi fa

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

Timeline cronologica

martedì 26 maggio 2026·biopharmadive.com
Early data for heart drug affirm Lilly’s billion-dollar bet on Verve
The base editing medicine lowered “bad” cholesterol levels along with a key protein, clearing the way for a Phase 2 study.
martedì 26 maggio 2026·benzinga.com
Chamath Palihapitiya Said This To Eli Lilly's Gene Therapy That Slashes LDL Cholesterol Up To 62% - Eli L
Chamath Palihapitiya reacted on X after Eli Lilly's VERVE-102 showed strong Phase 1b LDL cholesterol reduction results.

biopharmadive.com

1 mesi fa

Early data for heart drug affirm Lilly’s billion-dollar bet on Verve

The base editing medicine lowered “bad” cholesterol levels along with a key protein, clearing the way for a Phase 2 study.

Leggi questa versione → originale

gulfnews.com1 mesi fa

Why researchers are excited about a one-time cholesterol therapy

Discover why a one-time gene-editing cholesterol therapy could transform heart disease prevention

Leggi questa versione → originale

medpagetoday.com1 mesi fa

So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia

Tweaked lipid nanoparticle delivery system showed early safety

Leggi questa versione → originale

time.com1 mesi fa

A One-Time Experimental Treatment Might Control Cholesterol for Life

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular injections.

Leggi questa versione → originale

benzinga.com1 mesi fa

Chamath Palihapitiya Said This To Eli Lilly's Gene Therapy That Slashes LDL Cholesterol Up To 62% - Eli L

Chamath Palihapitiya reacted on X after Eli Lilly's VERVE-102 showed strong Phase 1b LDL cholesterol reduction results.

Leggi questa versione → originale

martedì 26 maggio 2026·

spectator.com

Gene-editing drugs are opening a new frontier in medicine

Medicines that we take only a few times and which permanently alter the trajectory of our lives for the better, are on the way.

martedì 26 maggio 2026·

medpagetoday.com

So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia

Tweaked lipid nanoparticle delivery system showed early safety

giovedì 28 maggio 2026·

arstechnica.com

One dose of gene-editing drug cut bad cholesterol 62% for months in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

giovedì 28 maggio 2026·

arstechnica.com

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

giovedì 28 maggio 2026·

time.com

A One-Time Experimental Treatment Might Control Cholesterol for Life

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular injections.

giovedì 28 maggio 2026·

abcnews.com

New drug could be game changer for people with high cholesterol

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer for treating high cholesterol.

venerdì 29 maggio 2026·

healio.com

PCSK9 inhibition via base editing lowers LDL in patients with genetic high cholesterol

Genetic PCSK9 inhibition via base editing appeared safe and demonstrated dose-dependent, durable reductions in PCSK9 and LDL cholesterol, researchers reported.At the highest dose,…

domenica 31 maggio 2026·

gulfnews.com

Why researchers are excited about a one-time cholesterol therapy

Discover why a one-time gene-editing cholesterol therapy could transform heart disease prevention